Details for 2019804326

Up to date per 01.04.2026

Actions

Title / Product Name

IN-VITRO- UND XENOTRANSPLANTAT-ANTITUMORAKTIVITÄT EINES HALOGENIERTEN XANTHENS GEGEN REFRAKTÄRE PÄDIATRISCHE SOLIDE TUMORE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019804326

EP Publication Number

3773548

E-Number

1596694

Language

PCT Number

US19032435

Publication Date

17.02.2021 A

09.08.2023 B1

Registration Date

09.08.2023

AT Publication Date

15.08.2023

Application Date

15.05.2019

Registration Number

Priorities

16.05.2018

201862672373 P

IPC

A61K 31/352 20060101AFI20230214BHEP

Maximum Duration of Protection

15.05.2039

Owner

Provectus Pharmatech, Inc.10025 Investment Drive, Suite 250 Knoxville, Tennessee 37932US

The Governors of the University of Calgary2500 University Drive NW Calgary, Alberta T2N 1N4CA

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

SINGER, Jamiec/o Provectus Pharmatech, Inc. 10025 Investment Drive, Suite 250 Knoxville, TN 37932US

WACHTER, Eric A.c/o Provectus Pharmatech, Inc. 10025 Investment Drive, Suite 250 Knoxville, TN 37932US

SWIFT, Lucyc/o University of Calgary, 2500 University Drive Nw Calgary, Alberta T2N 1N4CA

ZHANG, Chunfenc/o University of Calgary, 2500 University Drive NW Calgary, AB T2N 1N4CA

TRIPPETT, Tanyac/o Memorial Sloan Kettering Cancer Center, 405 Lexington Avenue, Suite 520 New York, NY 10174US

NARENDRAN, Aruc/o University of Calgary, 2500 University Drive NW Calgary, AB T2N 1N4CA

Information about Fees